Leslie Williams, hC Bioscience CEO
With a new startup, ARCH and Takeda wade into growing search for a Swiss Army knife RNA drug
ARCH and Takeda are stepping — if not quite leaping — into one of the hottest new areas in RNA drug development: tRNA.
On Wednesday the prominent …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
